Thus, the results of our study suggested that CNTD2 could be a valuable biomarker for the prediction of bladder cancer prognosis, and to the best of our knowledge, this is the first report to address that CNTD2 is associated with poor prognosis in bladder cancer. Here, CCNP is linked to urinary bladder carcinoma.